Autonomous Vehicle Processor Market Trends & Opportunities by 2030

Autonomous vehicles are the key to changing urban transportation beyond recognition in the next few years. Both traditional OEMs and new vehicle developers are working in this ecosystem to improve and introduce fully autonomous vehicles on the road. These vehicles will have advanced features as compared to traditional vehicles and enhance the driving experience for passengers.

The global autonomous vehicle processor market accounted for $5.07 billion in terms of value in 2019 and is expected to reach $42.20 billion by 2030. The market is anticipated to grow at a CAGR of 22.98% during the forecast period 2020-2030. The North America region is expected to grow at a significant growth rate of 24.09% during the forecast period 2020-2030.

Market Segmentation

• Application Type – Level 2, Level 3, Level 4, and Level 5

• Vehicle Type – Passenger Vehicles and Commercial Vehicles

Regional Segmentation

• North America - U.S. and Canada

• Europe – Germany, Netherlands, Sweden, and Rest-of-Europe

• Asia-Pacific and Japan (APJ) - South Korea, Japan, and Rest-of-APJ

• U.K.

• China

• South America

• Middle East and Africa (MEA)

Growth Drivers

• Transportation as a service is poised to accelerate the demand for new autonomous vehicle processors

• Increasing push from the government to develop connected and autonomous infrastructure

Market Challenges

• High-cost structure of autonomous vehicles and their processors

• Lack of advanced infrastructure in developing countries

• Autonomous vehicle protection from hackers is of paramount concern

• Global pandemic impacted the overall supply chain of automotive industry

Market Opportunities

• Tech manufacturers entering into autonomous processors business segment

• Autonomous vehicle platooning technology expected to grow exponentially

Key Companies Profiled

Intel Corporation, NXP Semiconductors N.V., Tesla, Inc., NVIDIA Corporation, Texas Instrument Incorporated, KALRAY Corporation, Renesas Electronic Corporation, Qualcomm Technologies, Inc., Xilinx, Inc., Hailo Technologies Ltd, Ambarella, Inc., AImotive

Request a Sample-https://bisresearch.com/requestsample?id=1059&type=download

Comments

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Market Research Reports

Search This Blog